Overview

MK0954A-264 Filter Study (0954A-264)(COMPLETED)

Status:
Completed

Trial end date:
2005-06-02

Target enrollment:

Participant gender:

Summary

To compare the blood pressure lowering efficacy, safety and tolerability of a combination drug to a single drug taken once daily in patients with uncontrolled blood pressure following a 4-week filter on the single therapy product.

Phase:

Phase 3

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Hydrochlorothiazide
Losartan